Table 1 Patient characteristics
Variable | Categories | Number of patients (%)* | |
|---|---|---|---|
Patients in study | 53 (100) | ||
Mesothelioma subtype | Epitheloid | 46 (87) | |
Sarcomatoid | 1 (2) | ||
Biphasic | 5 (9) | ||
Unknown | 1 (2) | ||
Sex | Male | 36 (68) | |
Female | 17 (32) | ||
Age | Mean | 69 (range 24–90) | |
Performance status | 0 | 4 (8) | |
1 | 28 (53) | ||
2 | 6 (11) | ||
3 | 2 (4) | ||
Unknown | 13 (25) | ||
Chemotherapy lines including current | 0 | 14 (26) | |
1 | 36 (68) | ||
2 | 2 (4) | ||
3 | 1 (2) | ||
Chemotherapy status while on the study | Given | 30 (56.6) | |
Mesomark prior to CT | 12 (40) | ||
Mesomark post CT | 18 (60) | ||
Not given | 23 (43) |